New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
October 20, 2023 - Sun Pharma and Teva launched AB-rated generic versions of Novartis’ Votrient (pazopanib) tablets.
Download PDF
Return to publications
